Learn how CEO fitness routines help leaders boost energy, sharpness, and discipline to stay at the top of their game every ...

Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 ...

Palantir's Q2 highlights surging AI adoption and 282% free cash flow growth. Despite premium valuation, PLTR's growth ...

First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the ...

The name Dogecoin has a special history for any investor who has been in the market for a few years. Today it commands real ...

Taboola is evolving beyond clickbait roots into a performance ad platform with major backers and strong open-web potential.